Latest news by Nicole

EU PERSPECTIVES - In an interview for EU Perspectives, Dr Christiaan Keijzer discusses the Critical Medicines Act (CMA), pharmaceutical legislation reform, and stresses why doctors must help shape Europe's medicine supply policies. Dr. Keijzer is an anaesthesiologist and anaesthesiology training director at Radboud University Medical Center in...

EU PERSPECTIVES - Brussels hailed the EU-US trade agreement as a "stabilising force" in uncertain times. But the deal has rattled Europe's pharmaceutical sector, with a 15 per cent tariff on EU-made medicines now on the table. The uncertainty has already triggered a wave of research and development investment announcements in the United...

EURACTIV - In this Euractiv interview, Enrico Piccinini, Senior Vice President, EU & International, Rare Diseases at Chiesi, calls for a comprehensive overhaul of the EU's approach to rare disease research, advocating for a more integrated ecosystem that nurtures early-stage scientific discovery, enhances patient access, and ensures sustained...

EU PERSPECTIVES - The European Commission's proposal for the next Multiannual Financial Framework (MFF), presented on 16 July 2025, doesn't shout "health", but it's there. From biotech to preparedness and scale-up funding, health innovation is a quiet yet strategic force running through Europe's bold new investment agenda for 2028–2034. Read more